One shot a week: How weekly Parkinson’s injection would be a game-changer for patients

Researchers at the University of South Australia have developed a novel, biodegradable gel for Parkinson’s disease treatment. This innovative injectable combines levodopa and carbidopa, providing steady drug levels for seven days. A once-weekly injection could replace multiple daily pills, improving patient adherence, reducing side effects, and offering stable symptom control for millions.